Amy Peterson
2017 - BeiGene, Ltd.
In 2017, Amy Peterson earned a total compensation of $3.1M as Chief Medical Officer Immuno, oncology at BeiGene, Ltd..
Compensation breakdown
| Bonus | $224,000 |
|---|---|
| Option Awards | $2,478,255 |
| Salary | $400,000 |
| Other | $8,100 |
| Total | $3,110,355 |
Peterson received $2.5M in option awards, accounting for 80% of the total pay in 2017.
Peterson also received $224K in bonus, $400K in salary and $8.1K in other compensation.
Rankings
In 2017, Amy Peterson's compensation ranked 3,478th out of 14,666 executives tracked by ExecPay. In other words, Peterson earned more than 76.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,478 out of 14,666 | 76th |
Division Manufacturing | 1,202 out of 5,772 | 79th |
Major group Chemicals And Allied Products | 331 out of 2,075 | 84th |
Industry group Drugs | 253 out of 1,731 | 85th |
Industry Pharmaceutical Preparations | 201 out of 1,333 | 85th |
Source: SEC filing on April 30, 2018.
Peterson's colleagues
We found five more compensation records of executives who worked with Amy Peterson at BeiGene, Ltd. in 2017.
2017
John Oyler
BeiGene, Ltd.
Chief Executive Officer
2017
Howard Liang
BeiGene, Ltd.
Chief Financial Officer
2017
Hematology Peterson
BeiGene, Ltd.
Chief Medical Officer
2017
Jane Huang
BeiGene, Ltd.
Chief Medical Officer
2017
Hematology Li
BeiGene, Ltd.
Executive Vice President Global Head of Business Development
News
CytomX Therapeutics CEO Sean McCarthy's 2022 pay falls 31% to $3M
April 27, 2023
CytomX Therapeutics CEO Sean McCarthy's 2021 pay jumps 52% to $4.3M
April 27, 2022
BeiGene, Ltd. CEO John Oyler's 2019 pay falls 55% to $13M
April 28, 2020
BeiGene, Ltd. CEO John Oyler's 2018 pay jumps 171% to $28M
April 29, 2019